Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-06-27 5:00 pm Purchase | 2023-06-26 | 13D | AEROVATE THERAPEUTICS INC AVTE | RA CAPITAL MANAGEMENT L.P. | 236,947 30.000% | 833 (+0.35%) | Filing History |
| 2023-06-21 5:00 pm Purchase | 2023-06-18 | 13D | DICE THERAPEUTICS INC DICE | RA CAPITAL MANAGEMENT L.P. | 7,877,862 16.500% | 217,247 (+2.84%) | Filing History |
| 2023-06-12 5:00 pm Sale | 2023-06-08 | 13D | SATSUMA PHARMACEUTICALS INC CO STSA | RA CAPITAL MANAGEMENT L.P. | 0 0.000% | -5,944,252 (Position Closed) | Filing History |
| 2023-06-05 4:31 pm Purchase | 2023-05-25 | 13G | 4D MOLECULAR THERAPEUTICS INC. FDMT | RA CAPITAL MANAGEMENT L.P. | 2,789,721 6.700% | 2,789,721 (New Position) | Filing History |
| 2023-05-30 5:00 pm Purchase | 2023-05-25 | 13D | ICOSAVAX INC ICVX | RA CAPITAL MANAGEMENT L.P. | 5,985,843 12.500% | 206,496 (+3.57%) | Filing History |
| 2023-05-15 5:02 pm Sale | 2023-05-15 | 13G | TRAVERE THERAPEUTICS INC TVTX | RA CAPITAL MANAGEMENT L.P. | 0 0.000% | -3,984,681 (Position Closed) | Filing History |
| 2023-05-15 5:01 pm Sale | 2023-05-15 | 13G | DA32 LIFE SCIENCE TECH ACQUISI DALS | RA CAPITAL MANAGEMENT L.P. | 0 0.000% | -1,500,000 (Position Closed) | Filing History |
| 2023-05-15 5:01 pm Sale | 2023-05-15 | 13G | ARYA SCIENCES ACQUISITION CORP ARYE | RA CAPITAL MANAGEMENT L.P. | 0 0.000% | -1,000,000 (Position Closed) | Filing History |
| 2023-04-18 4:30 pm Purchase | 2009-02-28 | 13D | SATSUMA PHARMACEUTICALS INC CO STSA | RA CAPITAL MANAGEMENT L.P. | 5,944,252 17.900% | 30,000 (+0.51%) | Filing History |
| 2023-04-10 5:05 pm Purchase | 2023-03-30 | 13G | NANOSTRING TECHNOLOGIES INC CO NSTGQ | RA CAPITAL MANAGEMENT L.P. | 2,577,373 5.500% | 2,433,473 (+1691.09%) | Filing History |
| 2023-04-10 5:01 pm Purchase | 2023-04-06 | 13D | CLIMB BIO, INC. CLYM | RA CAPITAL MANAGEMENT L.P. | 13,163,071 48.800% | 11,112 (+0.08%) | Filing History |
| 2023-04-10 5:00 pm Purchase | 2023-04-06 | 13G | ASCENDIS PHARMA A/S SPONSORED ASND | RA CAPITAL MANAGEMENT L.P. | 9,967,172 17.400% | 3,009,993 (+43.26%) | Filing History |
| 2023-03-30 5:08 pm Purchase | 2023-03-28 | 13G | GH RESH PLC SHS GHRS | RA CAPITAL MANAGEMENT L.P. | 5,561,118 10.700% | 662,745 (+13.53%) | Filing History |
| 2023-03-30 5:07 pm Purchase | 2023-03-28 | 13D | ACRIVON THERAPEUTICS INC ACRV | RA CAPITAL MANAGEMENT L.P. | 4,817,359 22.000% | 3,917 (+0.08%) | Filing History |
| 2023-03-30 5:02 pm Purchase | 2023-03-28 | 13D | 89BIO INC ETNB | RA CAPITAL MANAGEMENT L.P. | 12,876,898 18.000% | 6,717,844 (+109.07%) | Filing History |
| 2023-03-29 5:14 pm Purchase | 2023-03-27 | 13D | DICE THERAPEUTICS INC DICE | RA CAPITAL MANAGEMENT L.P. | 7,660,615 16.100% | 811,704 (+11.85%) | Filing History |
| 2023-03-27 5:00 pm Purchase | 2023-03-15 | 13G | CUREVAC N V CUREVAC N V IN CON CVAC | RA CAPITAL MANAGEMENT L.P. | 12,245,955 5.500% | 12,245,955 (New Position) | Filing History |
| 2023-03-20 4:30 pm Purchase | 2023-03-10 | 13G | ORCHARD THERAPEUTICS PLC ADS ORTX | RA CAPITAL MANAGEMENT L.P. | 18,564,300 9.990% | 18,564,300 (New Position) | Filing History |
| 2023-02-27 4:57 pm Sale | 2023-02-23 | 13G | IMARA INC IMRA | RA CAPITAL MANAGEMENT L.P. | 2,122,465 5.200% | -1,128,259 (-34.71%) | Filing History |
| 2023-02-24 4:30 pm Purchase | 2023-02-14 | 13D | MINERALYS THERAPEUTICS INC MLYS | RA CAPITAL MANAGEMENT L.P. | 3,180,920 7.800% | 3,180,920 (New Position) | Filing History |